All News

2058 articles, sorted by publication time.

Medical Testing · us

Distinguishing Infections Through the Immune Response: Access MeMed BV Receives FDA Clearance, Providing Clues in as Little as 15 Minutes

Bacterial and viral infections often have similar symptoms, but antibiotic decisions cannot always wait. This blood test brings host-response analysis to existing laboratory instruments and is intended for patients as young as 90 days old. Beyond speed, the key is how it is integrated with clinical judgment.

Gene and Cell Therapy · us

Directly Correcting the Sickle Cell Disease Mutation: UCLA Unveils a Clinical-Scale CRISPR Manufacturing Process

Four full-scale manufacturing batches met quality requirements, and the process has also produced cells for two early-stage trial participants. As gene correction moves toward treatment, the next test is whether the cells can sustain blood cell production in the human body over the long term and deliver lasting clinical benefits.

Medical Technology · us

Interpreting Incomplete Questionnaires: Quest2Dx Explores Parkinson’s Screening Through Cross-Dataset Validation

Finding disease signals in hundreds of health questions depends not only on detection performance, but also on whether results remain reliable with a different questionnaire. A new model demonstrates the ability to interpret responses across questionnaires, but further validation is needed to establish whether it can identify patients earlier in clinical practice.

Biotech Industry · global

Flagship combines three platforms to form Etcelera, betting on AI to identify disease causality

By connecting data on cell states, disease progression and experimental interventions, Etcelera hopes to determine earlier which small molecules merit entering clinical trials. The consolidation is supported by a development pipeline and pharmaceutical partnerships, but direct evidence that its predictions can translate into a higher drug development success rate remains lacking.

Cancer Research · global

Making Drugs with Cancer Cells’ Carbon Monoxide: RIKEN Demonstrates Intracellular Synthesis of Anticancer Molecules

Producing drugs only after delivery to tumors could open a new path toward reducing systemic toxicity. A Japanese team used albumin to protect a palladium-containing complex and synthesize active molecules inside cultured cancer cells. However, a small amount of reaction also occurred in normal cells, and efficacy and safety remain to be tested in animals.